Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-05

Clinical Trial Update: Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating the burden of nocturia using the Nocturia Impact Diary has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED | Results posted: 2017-05-05